0001415889-21-004264.txt : 20210907
0001415889-21-004264.hdr.sgml : 20210907
20210907171633
ACCESSION NUMBER: 0001415889-21-004264
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210902
FILED AS OF DATE: 20210907
DATE AS OF CHANGE: 20210907
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Rayner Craig R.
CENTRAL INDEX KEY: 0001834170
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39799
FILM NUMBER: 211240028
MAIL ADDRESS:
STREET 1: 100 OVERLOOK CENTER, SUITE 101
CITY: PRINCETON
STATE: NJ
ZIP: 08540
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Certara, Inc.
CENTRAL INDEX KEY: 0001827090
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-PREPACKAGED SOFTWARE [7372]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 OVERLOOK CENTER, SUITE 101
CITY: PRINCETON
STATE: NJ
ZIP: 08540
BUSINESS PHONE: (609) 716-7900
MAIL ADDRESS:
STREET 1: 100 OVERLOOK CENTER, SUITE 101
CITY: PRINCETON
STATE: NJ
ZIP: 08540
4
1
form4-09072021_020948.xml
X0306
4
2021-09-02
0001827090
Certara, Inc.
CERT
0001834170
Rayner Craig R.
C/O CERTARA, INC.
100 OVERLOOK CENTER, SUITE 101
PRINCETON
NJ
08540
false
true
false
false
PRESIDENT, INTEGRATED DRUG DEV
Common Stock
2021-09-02
4
S
0
3900
33.51
D
366572
D
Common Stock
2021-09-02
4
S
0
1900
34.15
D
364672
D
Common Stock
2021-09-02
4
S
0
48462
36.64
D
316210
D
Common Stock
2021-09-02
4
S
0
200
37.21
D
316010
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.
This transaction was executed in multiple trades at prices ranging from $32.91 to $33.88. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.
This transaction was executed in multiple trades at prices ranging from $34.12 to $34.33. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.
This transaction was executed in multiple trades at prices ranging from $36.19 to $37.18. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.
This transaction was executed in multiple trades at prices ranging from $37.21 to $37.22. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
/s/ Richard M. Traynor, Attorney-in Fact for Craig R. Raynor
2021-09-07